Erasme Hospital
Brussels, 1070, Belgium
NCT Number: NCT00821470
Aseptic non traumatic osteonecrosis (ON) is a painful disorder of the hip which often leads, in its final stage, to femoral head collapse and subsequent total hip replacement. Core decompression of the hip is the most widespread procedure used to treat early stage ON of the femoral head. Notwithstanding the fact that this procedure has been employed for more than three decades (2), its efficacy remains controversial (3;4). Recently, one suggested that ON might be a disease of bone cells and/or of mesenchymal cells. The levels of activity and the number of mesenchymal stem cells in both the hematopoietic and in the stromal compartments of the bone marrow have been shown to be depressed in patients with ON of the femoral head (9). The investigators have showed previously that the capacity of osteoblastic cells to replicate was decreased in the proximal femur of patients with ON of the femoral head (10). This finding raised the possibility that bone marrow containing stromal cells which have many of the characteristics of stem cell for mesenchymal tissues including bone could be implanted into the necrotic lesion of the femoral head.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 1
Brussels, 1070, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
core decompression procedure only
Time frame: 60 months
Time frame: 60 months
Erasme University Hospital
Other
Treatment of Osteonecrosis of the Femoral Head With Implantation of Autologous Bone Marrow Cells, a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06545058
Necrosis, Neurologic Manifestations
View Trial DetailsNCT04462315
Cardiovascular Diseases, Heart Disease
Seriate, Bergamo, Italy
View Trial DetailsNCT04145323
Breast Cancer, Breast Diseases
Madison, Wisconsin, United States
View Trial DetailsNCT01454713
Infection, Infections
San Diego, California, United States
View Trial Details